Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Trial-in-Progress: AMC 112: Axicabtagene Ciloleucel in Relapsed or Refractory HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphoma (NCT05077527)

Zachary D. Epstein-Peterson, Jeannette Y Lee, Stefan K. Barta, M. Lia Palomba, Ariela Noy

Blood (2022) 140 (Supplement 1): 12788–12789.

https://doi.org/10.1182/blood-2022-157292

Published: 2022

Journal Articles

Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)

Juan C. Ramos, Joseph A. Sparano, Amy Chadburn, Erin G. Reid, Richard F. Ambinder, Eric R. Siegel, Page C. Moore, Paul G. Rubinstein, Christine M. Durand, Ethel Cesarman, David Aboulafia, Robert Baiocchi, Lee Ratner, Lawrence Kaplan, Adam A. Capoferri, Jeannette Y. Lee, Ronald Mitsuyasu, Ariela Noy

Blood (2020) 136 (11): 1284–1297.

https://doi.org/10.1182/blood.2019003959

Published: 2020

Includes: Supplemental data

Journal Articles

Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's Lymphoma

Juan Carlos Ramos, MD BS, Richard F. Ambinder, MD, Joseph Sparano, MD, Jeannette Y Lee, PhD, Lawrence D Kaplan, MD, William Wachsman, MD PhD, David M. Aboulafia, MD, Ariela Noy, MD, Lee Ratner, MD PhD, David H. Henry, MD, Amy Chadburn, MD, Ethel Cesarman, MD PhD, Ronald T. Mitsuyasu, MD

Blood (2019) 134 (Supplement_1): 2872.

https://doi.org/10.1182/blood-2019-123558

Published: 2019

Journal Articles

A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes

Juan Carlos Ramos, MD BS, Joseph Sparano, MD, Page C. Moore, PhD, Eric Siegel, Jeannette Y Lee, PhD, Erin G. Reid, MD MS, Richard F. Ambinder, MD, Amy Chadburn, MD, Paul G. Rubinstein, MD, Christine Durand, Ethel Cesarman, MD PhD, Lee Ratner, MD PhD, Robert A Baiocchi, MD PhD, David M. Aboulafia, MD, Lawrence D Kaplan, MD, Adam Capoferri, Ronald T. Mitsuyasu, MD, Ariela Noy, MD

Blood (2019) 134 (Supplement_1): 1588.

https://doi.org/10.1182/blood-2019-129687

Published: 2019

Journal Articles

AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma

Ariela Noy, Jeannette Y. Lee, Ethel Cesarman, Richard Ambinder, Robert Baiocchi, Erin Reid, Lee Ratner, Nina Wagner-Johnston, Lawrence Kaplan

Blood (2015) 126 (2): 160–166.

https://doi.org/10.1182/blood-2015-01-623900

Published: 2015

Includes: Supplemental data

Journal Articles

AMC075: The Combination of Vorinostat with Chemotherapy and Rituximab Is Tolerable and Feasible in HIV-Related B-Cell Non-Hodgkin’s Lymphoma with High-Risk Features

Juan Carlos Ramos, MD, Joseph Sparano, MD, Page Moore, Jeannette Y. Lee, Michelle A Rudek, Richard F. Ambinder, Ethel Cesarman, MD PhD, Ariela Noy, MD, Ronald T. Mitsuyasu, MD

Blood (2014) 124 (21): 4473.

https://doi.org/10.1182/blood.V124.21.4473.4473

Published: 2014

Journal Articles

High Frequency of Identical Lymphoma Clones Detected in Pre-Treatment Tumor and Plasma from Untreated Patients with HIV-Associated Lymphomas: Prospective Multicenter Trial of the AIDS Malignancy Consortium (AMC 064)

Nina Wagner-Johnston, Jeannette Y. Lee, Sylvia Silver, Ariela Noy, Martha P. Mims, Francois Pepin, Martin Moorhead, PhD, Malek Faham, Richard F. Ambinder

Blood (2014) 124 (21): 1680.

https://doi.org/10.1182/blood.V124.21.1680.1680

Published: 2014

Journal Articles

Genome-wide scan identifies variant in 2q12.3 associated with risk for multiple myeloma

Stephen W. Erickson, Vinay R. Raj, Owen W. Stephens, Ishwori Dhakal, Shweta S. Chavan, Naveen Sanathkumar, Elizabeth Ann Coleman, Jeannette Y. Lee, Julia A. Goodwin, Senu Apewokin, Daohong Zhou, Joshua Epstein, Christoph J. Heuck, Annette J. Vangsted

Blood (2014) 124 (12): 2001–2003.

https://doi.org/10.1182/blood-2014-07-586701

Published: 2014

Includes: Supplemental data

Journal Articles

Chemotherapy-Induced Oral Mucositis: 11 SNPs Implicated In GWAS Of 972 Patients With Multiple Myeloma

Elizabeth Ann Coleman, PhD, Jeannette Y Lee, Ph.D., Stephen Erickson, Ph.D, Julia Goodwin, PhD, Marjorie Beggs, PhD, Naveen Sanathkumar, MD, Daohong Zhou, MD, Kent McKelvey, MD, Vinay Raj, Ph.D., Senu Apewokin, MD, Owen Stephens, Ph.D., Carol Enderlin, Ph.D., Annette Juul Vangsted, MD, Patty Reed, MS, Elias J. Anaissie, MD

Blood (2013) 122 (21): 3316.

https://doi.org/10.1182/blood.V122.21.3316.3316

Published: 2013

Journal Articles

Characterizing The CpG Methylation Of Epstein-Barr Virus DNA In The Plasma Of Patients With Hodgkin Lymphoma and HIV-Associated Burkitt Lymphoma

Jennifer A. Kanakry, Meir Shamay, Yvette L. Kasamon, Hailun Li, MS, Randy D. Gascoyne, MD, Leo I. Gordon, MD, Ariela Noy, MD, Ethel Cesarman, MD, PhD, Jeannette Y Lee, Ph.D., Sandra J. Horning, MD, Richard F. Ambinder

Blood (2013) 122 (21): 4232.

https://doi.org/10.1182/blood.V122.21.4232.4232

Published: 2013

Journal Articles

A Modified Dose Intensive R- CODOX-M/IVAC For HIV-Associated Burkitt and Atypical Burkitt Lymphoma(BL) Demonstrates High Cure Rates and Low Toxicity: Prospective Multicenter Phase II Trial Of The AIDS Malignancy Consortium (AMC 048)

Ariela Noy, MD, Lawrence Kaplan, MD, Jeannette Y Lee, Ph.D.

Blood (2013) 122 (21): 639.

https://doi.org/10.1182/blood.V122.21.639.639

Published: 2013

Journal Articles

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients

Blood (2013) 122 (19): 3251–3262.

https://doi.org/10.1182/blood-2013-04-498964

Published: 2013

Includes: Supplemental data

Journal Articles

ARL-IPI - A New Prognostic Score for AIDS-Related Lymphomas in the Rituximab Era

Stefan K Barta, MD, MS, MRCP, Xiaonan Xue, Ph.D., Dan Wang, MS, Jeannette Y Lee, Ph.D., Lawrence D. Kaplan, MD, Josep-Maria Ribera, MD, PhD, Albert Oriol, Olga Garcia, Mireia Morgades, Michele Spina, MD, Umberto Tirelli, MD, Francois Boue, MD, PhD, Wyndham H. Wilson, MD, PhD, Christoph Wyen, MD, Kieron Dunleavy, MD, Joseph A Sparano, MD

Blood (2012) 120 (21): 1564.

https://doi.org/10.1182/blood.V120.21.1564.1564

Published: 2012

Journal Articles

A Pooled Analysis of 1,546 Patients with HIV-Associated Lymphoma: Assessment of Lymphoma-, HIV-, and Treatment-Specific Factors On Clinical Outcomes

Blood (2012) 120 (21): 3682.

https://doi.org/10.1182/blood.V120.21.3682.3682

Published: 2012

Journal Articles

Pooled Analysis of Aids-Malignancy Consortium (AMC) Trials Evaluating Rituximab Plus Either CHOP or Infusional EPOCH Chemotherapy In HIV-Associated Non-Hodgkin's Lymphoma

Stefan K Barta, MD, MRCP, Jeannette Y Lee, Ph.D., Joseph A Sparano, MD, Lawrence D Kaplan, MD, Ariela Noy, MD

Blood (2010) 116 (21): 1797.

https://doi.org/10.1182/blood.V116.21.1797.1797

Published: 2010

Journal Articles

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

Blood (2010) 115 (15): 3008–3016.

https://doi.org/10.1182/blood-2009-08-231613

Published: 2010

Journal Articles

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010

Lawrence D. Kaplan, Jeannette Y. Lee, Richard F. Ambinder, Joseph A. Sparano, Ethel Cesarman, Amy Chadburn, Alexandra M. Levine, David T. Scadden

Blood (2005) 106 (5): 1538–1543.

https://doi.org/10.1182/blood-2005-04-1437

Published: 2005

NARROW

Trial-in-Progress: AMC 112: Axicabtagene Ciloleucel in Relapsed or Refractory HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphoma (NCT05077527)

Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)

Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's Lymphoma

A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes

AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma

AMC075: The Combination of Vorinostat with Chemotherapy and Rituximab Is Tolerable and Feasible in HIV-Related B-Cell Non-Hodgkin’s Lymphoma with High-Risk Features

High Frequency of Identical Lymphoma Clones Detected in Pre-Treatment Tumor and Plasma from Untreated Patients with HIV-Associated Lymphomas: Prospective Multicenter Trial of the AIDS Malignancy Consortium (AMC 064)

Genome-wide scan identifies variant in 2q12.3 associated with risk for multiple myeloma

Chemotherapy-Induced Oral Mucositis: 11 SNPs Implicated In GWAS Of 972 Patients With Multiple Myeloma

Characterizing The CpG Methylation Of Epstein-Barr Virus DNA In The Plasma Of Patients With Hodgkin Lymphoma and HIV-Associated Burkitt Lymphoma

A Modified Dose Intensive R- CODOX-M/IVAC For HIV-Associated Burkitt and Atypical Burkitt Lymphoma(BL) Demonstrates High Cure Rates and Low Toxicity: Prospective Multicenter Phase II Trial Of The AIDS Malignancy Consortium (AMC 048)

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients

ARL-IPI - A New Prognostic Score for AIDS-Related Lymphomas in the Rituximab Era

A Pooled Analysis of 1,546 Patients with HIV-Associated Lymphoma: Assessment of Lymphoma-, HIV-, and Treatment-Specific Factors On Clinical Outcomes

Pooled Analysis of Aids-Malignancy Consortium (AMC) Trials Evaluating Rituximab Plus Either CHOP or Infusional EPOCH Chemotherapy In HIV-Associated Non-Hodgkin's Lymphoma

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only